CD27
Basic information
Region (hg38): 12:6444955-6451718
Previous symbols: [ "TNFRSF7" ]
Links
Phenotypes
GenCC
Source:
- lymphoproliferative syndrome 2 (Moderate), mode of inheritance: AR
- autosomal recessive lymphoproliferative disease (Supportive), mode of inheritance: AR
- lymphoproliferative syndrome 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Lymphoproliferative syndrome 2 | AR | Allergy/Immunology/Infectious; Hematologic; Oncologic | The condition can involve childhood-onset immunodeficiency, and prophylactic measures, treatment, and prompt and aggressive treatment of infections may be beneficial; Individuals may manifest with hemophagocytic lymphohistiocytosis syndrome , and awareness can allow efficient management, but stem cell transplant may be indicated in such instances; Additional malignancies have been described, and awareness may allow recognition and treatment; HSCT has been described | Allergy/Immunology/Infectious; Hematologic; Oncologic | 22197273; 22365582; 22801960 |
ClinVar
This is a list of variants' phenotypes submitted to
- Lymphoproliferative_syndrome_2 (197 variants)
- Inborn_genetic_diseases (26 variants)
- not_provided (20 variants)
- not_specified (8 variants)
- Autoinflammatory_syndrome (6 variants)
- CD27-related_disorder (3 variants)
- Combined_immunodeficiency (2 variants)
- Immunodeficiency (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD27 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001242.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 52 | 53 | ||||
| missense | 102 | 106 | ||||
| nonsense | 5 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 11 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 11 | 6 | 104 | 54 | 1 |
Highest pathogenic variant AF is 0.000042142266
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CD27 | protein_coding | protein_coding | ENST00000266557 | 6 | 6852 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0100 | 0.948 | 125733 | 0 | 15 | 125748 | 0.0000596 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.132 | 148 | 153 | 0.970 | 0.00000841 | 1679 |
| Missense in Polyphen | 32 | 38.397 | 0.83341 | 445 | ||
| Synonymous | 0.252 | 56 | 58.4 | 0.958 | 0.00000323 | 514 |
| Loss of Function | 1.76 | 5 | 11.4 | 0.437 | 5.85e-7 | 122 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000123 | 0.000123 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000970 | 0.0000967 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000653 | 0.0000653 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for CD70/CD27L. May play a role in survival of activated T-cells. May play a role in apoptosis through association with SIVA1.;
- Disease
- DISEASE: Lymphoproliferative syndrome 2 (LPFS2) [MIM:615122]: An autosomal recessive immunodeficiency disorder associated with persistent symptomatic EBV viremia, hypogammaglobulinemia, and impaired T-cell-dependent B-cell responses and T-cell dysfunction. The phenotype is highly variable, ranging from asymptomatic borderline-low hypogammaglobulinemia, to a full-blown symptomatic systemic inflammatory response with life-threatening EBV-related complications, including hemophagocytic lymphohistiocytosis, a lymphoproliferative disorder, and malignant lymphoma requiring stem cell transplantation. {ECO:0000269|PubMed:22197273, ECO:0000269|PubMed:22801960}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Cytokine-cytokine receptor interaction - Homo sapiens (human);TNFR2 non-canonical NF-kB pathway;Cytokine Signaling in Immune system;Immune System;TNFs bind their physiological receptors
(Consensus)
Recessive Scores
- pRec
- 0.432
Intolerance Scores
- loftool
- 0.361
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.66
Haploinsufficiency Scores
- pHI
- 0.152
- hipred
- Y
- hipred_score
- 0.594
- ghis
- 0.565
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.743
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd27
- Phenotype
- immune system phenotype; hematopoietic system phenotype; cellular phenotype;
Gene ontology
- Biological process
- cell surface receptor signaling pathway;immunoglobulin mediated immune response;tumor necrosis factor-mediated signaling pathway;negative regulation of apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;response to ethanol;positive regulation of B cell differentiation;positive regulation of T cell differentiation;positive regulation of JNK cascade;negative regulation of T cell apoptotic process;extrinsic apoptotic signaling pathway;positive regulation of NIK/NF-kappaB signaling
- Cellular component
- extracellular region;plasma membrane;integral component of plasma membrane;external side of plasma membrane
- Molecular function
- transmembrane signaling receptor activity;protein binding;cysteine-type endopeptidase inhibitor activity involved in apoptotic process